Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dr. Hoenle AG ( (DE:HNL) ) just unveiled an announcement.
Dr. Hoenle AG announced the departure of Dr. Markus Arendt from its Management Board effective September 14, 2025, due to differing views on the company’s strategic direction. Dr. Franz Richter, the current Chairman of the Supervisory Board, will join the Management Board starting October 1, 2025, with his Supervisory Board mandate suspended during this period. The company remains focused on delivering planned growth and enhancing profitability. The Supervisory Board expressed gratitude for Dr. Arendt’s service and wished him well for the future.
The most recent analyst rating on (DE:HNL) stock is a Sell with a EUR8.00 price target. To see the full list of analyst forecasts on Dr. Hoenle AG stock, see the DE:HNL Stock Forecast page.
More about Dr. Hoenle AG
Hoenle AG is a publicly listed technology company based in Gilching, Germany, employing around 600 people. The company specializes in developing innovative solutions centered on UV technology for various industrial applications. Its business units include the development and marketing of industrial adhesives and adhesive-curing equipment, manufacturing systems for ink and coating curing for the printing and coatings industries, and environmentally friendly disinfection systems for water, air, and surfaces. Hoenle AG serves leading global technology and market leaders and operates in over 20 countries through its subsidiaries and partner companies.
Average Trading Volume: 5,239
Technical Sentiment Signal: Strong Sell
Current Market Cap: €49.71M
Find detailed analytics on HNL stock on TipRanks’ Stock Analysis page.